Pro Medicus Limited

ASX (AUD): Pro Medicus Limited (PME)

Last Price

171.35

Today's Change

+1.51 (0.88%)

Day's Change

169.72 - 173.42

Trading Volume

279,157

Overview

Market Cap

17 Billion

Shares Outstanding

104 Million

Avg Volume

289,473

Avg Price (50 Days)

144.02

Avg Price (200 Days)

117.35

PE Ratio

214.19

EPS

0.80

Earnings Announcement

14-Feb-2025

Previous Close

169.84

Open

173.42

Day's Range

169.72 - 173.42

Year Range

70.88 - 173.42

Trading Volume

279,157

Price Change Highlight

1 Day Change

0.89%

5 Day Change

3.67%

1 Month Change

14.23%

3 Month Change

26.01%

6 Month Change

76.45%

Ytd Change

77.93%

1 Year Change

140.32%

3 Year Change

190.28%

5 Year Change

496.21%

10 Year Change

18324.73%

Max Change

14800.00%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Health Information Services

Description:

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment